Insulin price cuts on the horizon in the US.
TL;DR Summary
Novo Nordisk will reduce the list prices of its insulin products by up to 75% starting January 1, 2022, including Levemir, Novolin, NovoLog, and NovoLog Mix70/30. The move comes after years of pressure on drug manufacturers to drop prices of the life-saving drug. The price cuts may save Novo millions, with upcoming changes to Medicaid forcing insulin manufacturers to pay rebates into the federal program if it did not implement caps. Insulin prices have been a major political issue in recent years, with the rocketing price of the drug putting many American families into a bind.
- Novo Nordisk plans price cuts for several insulins Daily Mail
- Here’s why slashing insulin prices will actually save Big Pharma money Ars Technica
- Insulin price caps are a welcome relief for many, but some diabetics are still waiting WTOL11
- Insulin products could be reducing in price in the U.S. WOAI
- Rep. Landsman introduces first bill aimed at capping insulin prices for children WLWT Cincinnati
Reading Insights
Total Reads
0
Unique Readers
10
Time Saved
3 min
vs 4 min read
Condensed
87%
761 → 96 words
Want the full story? Read the original article
Read on Daily Mail